A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. (Q53287201)
Jump to navigation
Jump to search
scientific article published in April 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. |
scientific article published in April 2007 |
Statements
A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. (English)
Christopher H van Dyck
Pierre N Tariot
Barnett Meyers
E Malca Resnick
Memantine MEM-MD-01 Study Group
1 April 2007
21
2
136-143